Zhejiang Pharmaceutical Industry

Company Deals

Baiyunshan to Acquire Zhejiang Pharma‑Industry for $500.5M, Expanding Distribution Network

Fineline Cube Dec 19, 2025

Guangzhou Baiyunshan Pharmaceutical Co., Ltd (SHA: 600332) announced its intention to acquire 100% equity of...

Company Drug

Novo Nordisk Submits CagriSema NDA for 20% Weight Loss in Obesity

Company Drug

Neurodawn’s Y-4 Wins FDA Fast Track for First‑in‑Class Neuropathic Pain Combo

Company Deals

Baiyunshan to Acquire Zhejiang Pharma‑Industry for $500.5M, Expanding Distribution Network

Others

Rona Therapeutics siRNA RN5681 Submitted to Australian Ethics Committee